Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
As the global healthcare landscape shifts toward weight-loss treatments and chronic care, investors are weighing two giants. Should…
AI Is Making a Mess of Nurses’ Schedules. They Say It’s a Safety Issue
Over the past four months, Amber Retzloff, a critical care nurse in Florida, requested to work 50 specific…
AI Is Making a Mess of Nurses’ Schedules. They Say It’s a Safety Issue
Over the past four months, Amber Retzloff, a critical care nurse in Florida, requested to work 50 specific…
A farmer left $10.9 million to build a cancer centre; Mayo Clinic was supposed to get it only if the local hospital lost its independence | World News
Iowa farmer Herman Carl Stille died in September 2020 at 94, leaving an estate worth about $10.9 million.…
Why are doctors paid less for procedures on women?
In the moody alcoves of a lobby bar in Chicago in 2021 over French 75s, Dr. Louise King,…
Wearable AI forecasts prolonged sitting in women with chronic pelvic pain disorders
Researchers at the Icahn School of Medicine at Mount Sinai have developed an artificial intelligence (AI) approach using…
Dad: Autism ‘miracle drug’ drastically improved my son’s symptoms
Like most 4-and-a-half-year-olds, Lev Bielski loves playing with his big sister, spelling his favorite pastime “pool” on the…
Johnson & Johnson vs. Eli Lilly: Which Pharma Stock Can Make Your Portfolio Healthier in 2026?
Choosing between the diversified stability of Johnson & Johnson (JNJ -2.30%) and the rapid growth trajectory of Eli…
Royal College of Nursing cuts ties with Israeli drug company | Health
Britain’s nursing union has cut its ties with an Israeli drug company over the firm’s links to the…
Wearable AI forecasts prolonged sitting in women with chronic pelvic pain
image: The illustration shows how the study used wearable data to forecast prolonged sedentary periods and inform future…
Could This Company Challenge Eli Lilly and Novo Nordisk in the Weight Loss Market?
Novo Nordisk (NVO -1.34%) has been a pioneer in the market for weight loss drugs, but Eli Lilly…
Will the SDPRIA survive the NSW election?
March 2027 is looking like a critical turning point for the troubled multi-billion-dollar Epic rollout. The Single Digital…